According to the current analysis of Reports and Data, the global Preimplantation genetic Diagnosis market was valued at USD 347.7 million in 2018 and is expected to reach USD 762.6 million by the year 2026, at a CAGR of 10.1%. Preimplantation genetic Diagnosis identifies genetic defects in embryos, which are developed through Vitro Fertilization (IVF) before pregnancy. Preimplantation genetic diagnosis (PGD) is made when one or both the hereditary parents have a known hereditary disorder, and testing is performed on the embryo to determine whether it carries the same hereditary disorder. It is used is growing due to; an increasing number of cases related to the predominance of genetic, hereditary and chromosomal diseases, rising knowledge amongst the population about the avoidance of genetic disorders.
A growing number of people suffering from genetic diseases are expected to increase the demand for Preimplantation genetic Diagnosis procedures to have a healthy child. Due to high pregnancy chances with the Preimplantation genetic Diagnosis procedure as compared to other fertility treatments, the demand for PGI testing is expected to witness high demand among people seeking IVF treatments.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2244
Further key findings from the report suggest
Availability of a significant number of services related to early diagnosis of specific gene mutation in embryo marked the dominant position of PGD in 2018 Preimplantation Genetic Screening (PGS) seems to be a reasonable intervention to enhance the efficiency of selecting chromosomally normal embryo during IVF cycles. It is increasingly being applied for embryo screening due to ever-expanding IVF, which is projected to create lucrative growth opportunities in the near future Advancements in the detection of chromosomal anomalies by executing non-invasive prenatal testing results in a maximum share of this segment in 2018 The market chromosomal abnormalities segment is expected to reach USD 271.0 million by the year 2026, growing at a CAGR of 6.8% during the forecast periodEnlarging utilization rate of FISH probe sets and benefits associated with the detection of a single-gene disorder is anticipated to fuel the growth of X-linked diseases segment Increasing use Of PGT in embryo HLA typing for stem cell therapy is expected to boost segment growth. This further proceeds to the advantages of PGS testing for the identification of HLA compatible embryos during stem cell therapy North America holds the largest revenue share of 32.0% in 2018 due to an increased usage of PGD and PGS for the delivery of genetically healthy offspring during IVF procedures.Asia Pacificmarket is observed to showcase the fastest growing CAGR due to the rise in medical tourism and rising development of IVF and PGD clinics in Asian countries.Key participants are actively involved in the expansion of the distribution network for their products as well as R&D activities for the development of novel PGT services. In October 2018, Illumina Inc. joined an agreement with Vitrolife AB under which Vitrolife act as a distributor supplier of Illumina's PGT products in EMEA and America.Top Players in the Global Preimplantation Genetic Diagnosis Market:
Natera, Inc.; CooperSurgical, Inc.; F. Hoffmann-La Roche AG; Illumina, Inc.; IGENOMIX; and others
The coronavirus pandemic has had a drastic impact on the global healthcare industry, with rising cases of COVID-19 worldwide, substantially growing hospital admission and readmission rates, and rising demand for telehealth and telemedicine services for remote patient monitoring. Furthermore, rising focus on development of rapid COVID-19 diagnostics such as the RT-PCR test kits, increased government funding for vaccine development, stringent regulatory norms and protocols for COVID-19 safety, and increasing sales of COVID-19 safety equipment, such as N-95 masks, face shields, PPE kits, and hand sanitizers, have driven the global pharma & healthcare industry revenue growth over the recent past.
To know more about the report @ https://www.reportsanddata.com/report-detail/preimplantation-genetic-testing-market
Preimplantation genetic Diagnosis Market Segmentation:
Test Type (Revenue, USD Million; 2016–2026)
Preimplantation Genetic Diagnosis (PGD)Preimplantation Genetic Screening (PGS)Type (Revenue, USD Million; 2016–2026)
Chromosomal AbnormalitiesX-linked DiseasesEmbryo TestingAneuploidy ScreeningHLA TypingOther PGT TypesApplication (Revenue, USD Million; 2016–2026)
Embryo HLA Typing for Stem Cell TherapyIVF PrognosisLate Onset Genetic DisordersInherited Genetic DiseaseOthersEnd Use (Revenue, USD Million; 2016–2026)
Maternity Centers & Fertility ClinicsHospitals, Diagnostic Labs, and Service ProvidersResearch Laboratories & Academic InstitutesGlobal Preimplantation genetic Diagnosis Market Report: Regional Segmentation
North AmericaEuropeAsia PacificLatin AmericaMiddle East & AfricaRequest customization of the report @ https://www.reportsanddata.com/request-customization-form/2244
Read More Reports:
Blood Culture Tests Market @ https://www.reportsanddata.com/report-detail/blood-culture-tests-market
Obesity Treatment Market @ https://www.reportsanddata.com/report-detail/obesity-treatment-market
Medical Foods Market @ https://www.reportsanddata.com/report-detail/medical-foods-market
Cancer Immunotherapy Market @ https://www.reportsanddata.com/report-detail/cancer-immunotherapy-market
Electrocardiograph Market @ https://www.reportsanddata.com/report-detail/electrocardiograph-market
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.
0
Sign in to leave a comment.